Pathway analysis showed in ALS patients major down-regulations in genes related to glutamate metabolism, such as CCBL2, also called KAT3 (Kynurenine aminotransferase), supporting the role of glutamate-induced excitotoxicity in ALS pathogenesis, coherently with previous reports35. The gene discussed is KYAT3; the disease is amyotrophic lateral sclerosis.